Highbridge Capital Management’s Usana Health Sciences USNA Stock Holding History

Highbridge Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,415	Closed	-$254K	–	1624
2017 Q1	$254K	Buy	+4,415	New	+$264K	﹤0.01%	1224
2016 Q2	–	Sell	-4,442	Closed	-$269K	–	1777
2016 Q1	$269K	Sell	4,442 -28,432	-86%	-$1.67M	﹤0.01%	1226
2015 Q4	$2.1M	Buy	+32,874	New	+$2.13M	0.03%	503
2015 Q3	–	Sell	-8,216	Closed	-$562K	–	1829
2015 Q2	$562K	Buy	8,216 +3,448	+72%	+$219K	0.01%	911
2015 Q1	$265K	Buy	+4,768	New	+$244K	﹤0.01%	1178

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highbridge Capital Management's USNA Position: Q2 2017 in Review

Highbridge Capital Management sold out of Usana Health Sciences (USNA) in Q2 2017, closing a stake of 4,415 shares — an estimated $254K sold.

Highbridge Capital Management first reported a position in USNA in Q1 2015 and held it in 5 quarters. The position peaked at $2.1M in Q4 2015. 145 funds tracked by Wall St. Rank hold USNA as of Q2 2017.

Highbridge Capital Management reported no remaining Usana Health Sciences position as of Q2 2017 after selling out during the quarter.
Highbridge Capital Management sold 4,415 Usana Health Sciences shares in Q2 2017, an estimated $254K.
Highbridge Capital Management first reported a position in Usana Health Sciences in Q1 2015 and held it in 5 quarters.
Highbridge Capital Management's Usana Health Sciences position peaked at $2.1M in Q4 2015.
145 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.